Baijie cancer antigen CA19-9 enzyme immunoassay group - Taiwan Registration f10887d5f2e11f6320a8f457d6d80973
Access comprehensive regulatory information for Baijie cancer antigen CA19-9 enzyme immunoassay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f10887d5f2e11f6320a8f457d6d80973 and manufactured by BIOCHECK, INC.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
It is used for the quantitative analysis of serum haze of tumor antigen CA19-9.
C Immunology and microbiology
C.6010 ่ ซ็ค็ธ้ๆๅๅ ็ซ่ฉฆ้ฉ็ณป็ตฑ
import
Dates and Status
Dec 13, 2006
Dec 13, 2011
May 05, 2014
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ